Lori Muffly MD, MS, Stanford Medicine, Stanford, CA Recorded on May 12, 2026 Lori Muffly MD, MS Professor of Medicine Division of Blood and Marrow Transplantation & Cellular Therapy Stanford Medicine Stanford, CA In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams, and resources to support patients and healthcare professionals. Join us for this insightful episode on the important role of HSCT today, and where it’s headed next. Mentioned on this episode: www.NMDP.org www.hematology.org Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Treating Blood Cancers
Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology Care
Driving Progress in AML
Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment
Optimizing Outcomes in Myeloma
Get summaries like this every morning.
Free AI-powered recaps of Treating Blood Cancers and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.